$1.50
-0.08 (-5.06%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,025.3% upside
Low Target
$19.01
Average Target
$31.88
High Target
$45.37
Current Price
$1.50
Current
$1.50
$1.50
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Scenario Analysis
Bear Case
$19.01
1,167.3%
Low target
Base Case
$31.88
+2,025.3%
Avg target
Bull Case
$45.37
+2,924.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$5.07
-70.4% from high
52-Week Low
$0.99
+51.9% from low
Target vs 52W High
$31.88
+528.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.2% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.7% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.6% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.8% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.2% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.5% |